Digital Health Global

APRIL 5, 2024

The report provides forecasts by application, distribution channel, and country alongside a rigorous market analysis and executive guidance. This latest analysis is expected to be of significant interest to stakeholders, healthcare providers, and investors looking to understand and capitalize on this rapidly growing market segment.

BioTech 88

BioTech Digital Health Medicare Telehealth 88

Health Populi

JUNE 24, 2021

While telehealth and virtual care stood up quickly in 2020, questions remain about how it will/can persist in terms of funding, regulation, and business models. We also expect innovation to come out of pharma and biotech labs, and who will pay for new-new therapies?

BioTech 270

BioTech Pharmaceuticals Public Health Telehealth 270

Healthcare IT Today

JANUARY 8, 2024

Given the improvements in costs, trial sponsors can now take advantage of these exchanges at scale and leverage the data for both pre-screening and health economic analysis. As DCTs and virtual site acceptance accelerates, a knock-on effect will be that more of these trials will include HEOR analysis. Dave Latshaw, CEO at BioPhy 1.

Health IT 83

Health IT Drug Development Pharmaceuticals BioTech 83

Digital Health Global

NOVEMBER 20, 2023

Drawing on AstraZeneca’s deep experience of developing novel therapeutics and with insights from thousands of patients and clinical researchers, Evinova will provide established technology solutions to pharma, biotech and CROs to support clinical research globally. Available at: [link]. Accessed November 2023.

Life Science 88

Life Science Digital Health Drug Development Patient Experience 88